Skip to main content

Advertisement

Table 2 Clinical outcomes of for the patients in the intervention group and in the control group

From: Vitamin D3 supplementation and treatment outcomes in patients with depression (D3-vit-dep)

  Intervention group (n = 28) Control group (n = 34) p values
Baseline 12 weeks 24 weeks Baseline 12 weeks 24 weeks 12 weeks 24 weeks
Hamilton 18.4 (5.73) 10.6 (5.40) 9.26 (6.32) 18.0 (6.01) 9.50 (5.48) 9.59 (7.82) 0.73 0.17
MDI 33.4 (10.7) 21.8 (10.5) 16.4 (12.0) 33.8 (7.77) 20.4 (10.5) 19.5 (11.6) 0.83 0.57
WHO-5 23.8 (15.3) 37.0 (25.3) 50.5 (29.0) 24.0 (17.2) 39.5 (21.2) 47.2 (22.4) 0.89 0.49
Vitamin D 43.2 (24.6) 94.5 (30.0) 97.9 (25.0) 44.3 (24.1) 44.4 (25.0) 52.0 (33.5)   
  1. Values are mean (SD) unless stated otherwise
  2. Hamilton Hamilton Rating Scale for depression (HRSD-17), MDI major depression inventory, WHO5 WHO5 Well-being Index, Vitamin D 25(OH)D level
  3. The mean (SD) decrease in the intervention were: − 9.58 (6.2); the mean (SD) decrease in the control group were: − 7.1 (6.2); (p = 0.17). The decrease in depression scores in both groups were significantly (p < 0.001)